IGFBP2 and pulmonary arterial hypertension: Increased IGFBP-2 levels are associated with disease severity and adverse outcomes, particularly in patients at risk for heart failure and pulmonary arterial hypertension, due to its critical role in vascular remodeling and systemic inflammation [145].